Literature DB >> 17702714

Therapeutic drug monitoring of mycophenolic acid.

Leslie M Shaw1, Michal Figurski, Michael C Milone, Jennifer Trofe, Roy D Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17702714     DOI： 10.2215/CJN.03861106

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  16 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  Large scale analysis of routine dose adjustments of mycophenolate mofetil based on global exposure in renal transplant patients.

Authors:  Franck Saint-Marcoux; Soizic Vandierdonck; Aurélie Prémaud; Jean Debord; Annick Rousseau; Pierre Marquet
Journal:  Ther Drug Monit       Date:  2011-06       Impact factor: 3.681

3.  Comment on "Population Pharmacokinetics of Mycophenolic Acid: An Update".

Authors:  Jean-Baptiste Woillard; Jean Debord; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

4.  Drug monitoring for mycophenolic acid in graft-vs-host disease prophylaxis in cord blood transplantation.

Authors:  Hiroyuki Muranushi; Junya Kanda; Yasuyuki Arai; Takero Shindo; Masakatsu Hishizawa; Takashi Yamamoto; Tadakazu Kondo; Kohei Yamashita; Kazuo Matsubara; Akifumi Takaori-Kondo
Journal:  Br J Clin Pharmacol       Date:  2020-05-30       Impact factor: 4.335

5.  Population pharmacokinetics of mycophenolic acid in lung transplant recipients with and without cystic fibrosis.

Authors:  Xiao-Xing Wang; Meihua R Feng; Hugh Nguyen; David E Smith; Diane M Cibrik; Jeong M Park
Journal:  Eur J Clin Pharmacol       Date:  2015-05-07       Impact factor: 2.953

6.  Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.

Authors:  Malek Okour; Pamala A Jacobson; Mariam A Ahmed; Ajay K Israni; Richard C Brundage
Journal:  J Clin Pharmacol       Date:  2018-01-12       Impact factor: 3.126

7.  Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.

Authors:  Tsuyoshi Fukuda; Jens Goebel; Håvard Thøgersen; Denise Maseck; Shareen Cox; Barbara Logan; Joseph Sherbotie; Mouin Seikaly; Alexander A Vinks
Journal:  J Clin Pharmacol       Date:  2010-04-23       Impact factor: 3.126

8.  Pharmacokinetics and dynamics of mycophenolate mofetil after single-dose oral administration in juvenile dachshunds.

Authors:  M Grobman; D M Boothe; H Rindt; B G Williamson; M L Katz; J R Coates; C R Reinero
Journal:  J Vet Pharmacol Ther       Date:  2017-06-25       Impact factor: 1.786

9.  Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.

Authors:  Laurent R Chiarelli; Mariadelfina Molinaro; Carmelo Libetta; Carmine Tinelli; Laura Cosmai; Giovanna Valentini; Antonio Dal Canton; Mario Regazzi
Journal:  Br J Clin Pharmacol       Date:  2010-01       Impact factor: 4.335

Review 10.  Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients.

Authors:  Daping Zhang; Diana S-L Chow
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.